Cargando…

Estrogen receptor α polymorphism is associated with dementia in a Brazilian cohort

The growth of the elderly population is a worldwide phenomenon and it is associated with chronic diseases, including dementia. In this scenario, the present study aimed to evaluate a possible association of estrogen receptor α polymorphisms with dementia in a Brazilian cohort. The subject sample was...

Descripción completa

Detalles Bibliográficos
Autores principales: Magnago, Rafaella Papalino Lopes, Barauna, Valerio Garrone, Brun, Bruna Ferro, Lo Prete, Ana Cristina, Alvarenga, Aline Morgan, Gastalho Campos, Luciene C., Rochette, Neuza Felix Gomes, Rangel, Letícia Batista Azevedo, Faria, Rodrigo Alves, Santos, Paulo Caleb Junior Lima, Silva, Ian Victor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747857/
https://www.ncbi.nlm.nih.gov/pubmed/33400738
http://dx.doi.org/10.18632/oncotarget.27744
Descripción
Sumario:The growth of the elderly population is a worldwide phenomenon and it is associated with chronic diseases, including dementia. In this scenario, the present study aimed to evaluate a possible association of estrogen receptor α polymorphisms with dementia in a Brazilian cohort. The subject sample was divided into two groups, control (n = 105) and case (n = 73), according to analysis of two predictive dementia tests (MMSE and CDR). The genotyping for the ERα PvuII (c.454-397T>C, rs2234693) and XbaI (c.454-351A>G, rs9340799) polymorphisms were performed by polymerase chain reaction-restriction fragment length polymorphism. The ERα PvuII pp genotype was associated with higher odds ratio for dementia (OR = 3.42, 95% CI = 1.33–8.77, p = 0.01, in a model including covariates. A linear regression model identified significant associations of the ERα PvuII genotypes (independent variable) with CDR scale (dependent variable), β = 0.26 and p = 0.001. In conclusion, estrogen receptor α PvuII polymorphism is associated with dementia in a Brazilian cohort. This finding may be useful for the identification of a possible set of significant genetic and clinical biomarkers for better understanding pathophysiology, early diagnosis and management of dementia.